Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-07-21
2000-01-25
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 21, 530324, 530412, 530402, A61K 3816
Patent
active
060178760
ABSTRACT:
The present invention broadly relates to chemical modification of biologically active proteins or analogs thereof. More specifically, the present invention describes novel methods for site-specific chemical modification of various proteins, and resultant compositions having improved biocompatibility and bioactivity.
REFERENCES:
patent: 4931544 (1990-06-01), Katre et al.
patent: 4955857 (1990-09-01), Shettigar
patent: 5214132 (1993-05-01), Kuga et al.
patent: 5635180 (1997-06-01), Morgan, Jr. et al.
patent: 5677422 (1997-10-01), Safarian et al.
patent: 5900404 (1999-05-01), Gegg et al.
Holcenberg et al., The Journal of Biological Chemistry, vol. 250, No. 71, 4165-4170 (1975).
Gegg Colin
Kinstler Olaf
Amgen Inc.
Crandall Craig A.
Levy Ron K.
Moezie F. T.
Odre Steven M.
LandOfFree
Chemical modification of granulocyte-colony stimulating factor ( does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemical modification of granulocyte-colony stimulating factor (, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical modification of granulocyte-colony stimulating factor ( will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2315954